Drugs / 5% dextrose
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable2 trials | ||||||
| — | NCT02986906 | Mar 2017 → Oct 2019 | ulnar neuropathy | Tri-Service General Hospital (TSGH) | Completed | No outcome recorded |
| — | NCT00995670 | Mar 2010 → Sep 2013 | hyperglycemia | US Department of Veterans Affairs | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| — | NCT06522204 Background | Jul 2024 → Dec 2025 | — | Karaman Training and Research Hospital | Completed | No outcome recorded |
| — | NCT05244902 Background | Mar → Aug 2022 | — | Karaman Training and Research Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 5% dextrose | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00995670 ↗ |
| Route | Oral | “All the patients will receive oral 3mL/kg 5%Dextrose” NCT05244902 ↗ |